The 2021 Inpatient Prospective Payment System (IPPS) final rule ushered in a host of coding changes. Review new codes, MS-DRG updates, and other changes to ensure your organization is in compliance.
The complexity and competitiveness of today’s business environment require that organizations have early warning systems to identify times when they face certain risks. Compliance officers should be active participants in the organization’s risk assessment process.
Q: For the purposes of determining a Medicare overpayment, should claims that we are uncertain whether they were appropriate be included? Is this defined under the False Claims Act (FCA)?
Q: CMS created a new MS-DRG for chimeric antigen receptor T-cell (CAR-T) therapies in the fiscal year (FY) 2021 IPPS final rule. Which ICD-10-PCS codes group to this new MS-DRG and does it qualify for an additional new technology add-on payment?
